Kayne Anderson Rudnick Investment Management LLC Vertex Pharmaceuticals Inc Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 13,101 shares of VRTX stock, worth $5.91 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,101

Previous 13,426 2.42%

Holding current value

$5.91 Million

Previous $6.29 Million 3.18%

% of portfolio

0.01%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $149,500 - $164,378	-325 Reduced 2.42%	13,101 $6.09 Million
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $115,093 - $142,260	-293 Reduced 2.14%	13,426 $6.29 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $196,914 - $215,456	-483 Reduced 3.4%	13,719 $5.73 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $192,423 - $230,391	-561 Reduced 3.8%	14,202 $5.78 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $37,537 - $40,233	-111 Reduced 0.75%	14,763 $5.13 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $70,115 - $78,475	-223 Reduced 1.48%	14,874 $5.23 Million
Q1 2023 May 16, 2023	BUY	$283.23 - $323.1 $1,132 - $1,292	4 Added 0.03%	15,097 $4.76 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $182,600 - $205,425	-639 Reduced 4.06%	15,093 $4.36 Million
Q3 2022 Nov 16, 2022	BUY	$273.83 - $305.53 $4.31 Million - $4.81 Million	15,732 New	15,732 $4.56 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $2,738 - $3,055	-10 Closed	0 $4.56 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $6,108 - $7,606	-26 Reduced 72.22%	10 $3,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $5,756 - $6,785	26 Added 260.0%	36 $9,000
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $4,346 - $5,152	-17 Reduced 62.96%	10 $3,000
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $1,667 - $2,239	10 Added 58.82%	27 $6,000
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $2,798 - $3,236	17 New	17 $3,000

Others Institutions Holding VRTX

# of Institutions

1,721

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account

Kayne Anderson Rudnick Investment Management LLC Vertex Pharmaceuticals Inc Transaction History